is glp-1 insulin The Role of Receptor Agonists in Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome ๐ง๐ต๐ฒ ๐๐ณ๐ณ๐ฒ๐ฐ๐ ๐ผ๐ณ ๐๐๐ฃ-๐ญ ๐ฅ๐ฒ๐ฐ๐ฒ๐ฝ๐๐ผ๐ฟ
Description
Liver and pancreatic effects Transient increases in liver enzymes (ALT) exceeding three times the upper normal limit occurred in roughly 1% of participants receiving retatrutide
First-line treatments include topical clotrimazole pessaries or oral fluconazole 150 mg, with no significant drug interactions with semaglutide

Ben-Shlomo S, Zvibel I, Shnell M, Shlomai A, Chepurko E, Halpern Z, et al

Sponsors must be sure that Prescription Drug Plan Documents and SPDs (and Summaries for Non-ERISA Plans) are well constructed and reviewed, include appropriate formulary references and required PBM program language

[DOI] [PMC free article] [PubMed] [Google Scholar] 27.Dhillon S
